Login to Your Account

Developing Nicotinic Receptor Drugs, Targacept Raises $46M

By Aaron Lorenzo

Friday, December 6, 2002
Its science rooted deep in North Carolina tobacco country, Targacept Inc. continues to impress observers with its neuronal nicotinic receptor approach to drug discovery. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription